The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

22 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
[1,2]Oxazolo[5,4-e]isoindoles as promising tubulin polymerization inhibitors.EBI
University of Palermo
Water-soluble isoindolo[2,1-a]quinoxalin-6-imines: in vitro antiproliferative activity and molecular mechanism(s) of action.EBI
University of Palermo
Novel 1H-pyrrolo[2,3-b]pyridine derivative nortopsentin analogues: synthesis and antitumor activity in peritoneal mesothelioma experimental models.EBI
University of Palermo
3D-QSAR pharmacophore modeling and in silico screening of new Bcl-xl inhibitors.EBI
University of Palermo
Identification of 6,9-dihydro-5H-pyrrolo[3,2-h]quinazolines as a new class of F508del-CFTR correctors for the treatment of cystic fibrosis.EBI
University of Palermo
Bioisosteric heterocyclic analogues of natural bioactive flavonoids by scaffold-hopping approaches: State-of-the-art and perspectives in medicinal chemistry.EBI
University of Palermo
1,2,4-Amino-triazine derivatives as pyruvate dehydrogenase kinase inhibitors: Synthesis and pharmacological evaluation.EBI
University of Palermo
Insight into non-nucleoside triazole-based systems as viral polymerases inhibitors.EBI
University of Palermo
Quinoline anticancer agents active on DNA and DNA-interacting proteins: From classical to emerging therapeutic targets.EBI
University of Palermo
Bioactive pyrrole-based compounds with target selectivity.EBI
University of Palermo
Current development of CFTR potentiators in the last decade.EBI
University of Palermo
Targeting SARS-CoV-2 Main Protease for Treatment of COVID-19: Covalent Inhibitors Structure-Activity Relationship Insights and Evolution Perspectives.EBI
University of Palermo
Synthesis of 2H-Imidazo[2',1':2,3] [1,3]thiazolo[4,5-e]isoindol-8-yl-phenylureas with promising therapeutic features for the treatment of acute myeloid leukemia (AML) with FLT3/ITD mutations.EBI
University of Palermo
Metabolomics-assisted discovery of a new anticancer GLS-1 inhibitor chemotype from a nortopsentin-inspired library: From phenotype screening to target identification.EBI
University of Palermo
Pyrrolomycins as antimicrobial agents. Microwave-assisted organic synthesis and insights into their antimicrobial mechanism of action.EBI
University of Palermo
An overview on chemical structures as ΔF508-CFTR correctors.EBI
University of Palermo
Synthetic small molecules as anti-biofilm agents in the struggle against antibiotic resistance.EBI
University of Palermo
Synthesis and biological activities of a new class of heat shock protein 90 inhibitors, designed by energy-based pharmacophore virtual screening.EBI
University of Palermo
1,3,5-Triazines: A promising scaffold for anticancer drugs development.EBI
University of Palermo
Synthesis and antitumor activities of 1,2,3-triazines and their benzo- and heterofused derivatives.EBI
University of Palermo
Synthesis, antitumor activity and CDK1 inhibiton of new thiazole nortopsentin analogues.EBI
University of Palermo
Pharmaceutical Approaches to Target Antibiotic Resistance Mechanisms.EBI
University of Palermo